Valvular & structural heart disease

Impact of Residual Transmitral Mean Pressure Gradient on Outcomes After Mitral Transcatheter Edge-to-Edge Repair

JACC AdvPublished Retrospective cohort study

Main finding · All-cause mortality or HF hospitalizationResult — go to the resultAdjusted hazard ratio 1.53 95% CI 1.03–2.26

Authors' conclusion

In this single-center study, higher residual TMPG after M-TEER was associated with worse outcomes at intermediate- to long-term follow-up.

Study context

Population
Consecutive patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) at one institution, 2014–2022
Participants
283 patients
Exposure
Predischarge transmitral mean pressure gradient (TMPG) quartile 4 vs quartiles 1 to 3 after M-TEER
Outcome
All-cause mortality or HF hospitalization
Follow-up
3 years
Methodological detailssingle-centre, consecutive patients
  • Single-centre
  • Consecutive patients

Main finding

All-cause mortality or HF hospitalization

Adjusted hazard ratio

1.53

95% CI 1.03–2.26

P = 0.034

Quartile 4 vs Quartiles 1 to 3
adjHR 1.53 (95% CI 1.03–2.26); P = 0.034

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeadjHR (95% CI)P value
All-cause mortality alone · 3 years1.68 (1.09–2.60)P = 0.020

Primary mitral regurgitation (MR) (subgroup): all-cause mortality or HF hospitalization, and all-cause mortality

Primary MR, composite endpoint, adjHR
2.08 (1.15-3.77); P = 0.016 (95% CI)
Primary MR, all-cause mortality, adjHR
2.70 (1.40-5.19); P = 0.003 (95% CI)

Secondary MR (subgroup)

Association did not reach statistical significance in secondary MR

Predictor of increased TMPG after M-TEER: higher baseline TMPG

Baseline TMPG coefficient
0.60 (0.40-0.70); P < 0.001 (95% CI)

Original publication

Impact of Residual Transmitral Mean Pressure Gradient on Outcomes After Mitral Transcatheter Edge-to-Edge Repair. JACC Adv. Published 4 September 2024. doi:10.1016/j.jacadv.2024.101227

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.